Twist Bioscience Corporation (TWST) at a glance

Twist Bioscience Corporation (TWST) is a mid-cap Healthcare company. It trades at $127.22, with a -19.8% profit margin and revenue growth of 19.3%. It does not pay a dividend. Vestovix scores it 44/100 overall. Its strongest dimension is Growth (75/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.

Price

$127.22

Market cap

$4.74B

P/E ratio

n/a

Dividend yield

None

Beta

2.21

52-week range

$23.30 to $155.43